---
vault_clearance: THAUMIEL
halo:
  classification: THEORY — THE BRAIN SENDS WRONG VOLTAGE TO HSCs (AND OTHER QUIESCENT POPULATIONS) IN AGING/AD; HSC V_MEM AS THE KEYSTONE UNMEASURED LINK
  confidence: DATA (Méndez-Ferrer 2008 Nature SCN→sympathetic→β3-AR→CXCL12→HSC quiescence; Maryanovich 2018 Nat Med aged BM has 3-fold loss of sympathetic nerve fibers + β3-agonist rejuvenates HSCs; Ho 2024 Leukemia sympathetic neuropathy enables clonal hematopoiesis; AD documented sympathetic-dominant autonomic dysfunction; AFT024 niche stromal cell V_mem -14 mV → -35 mV with NCX1 block) + FRAMEWORK (the V_mem keystone connecting brain → HSC niche → quiescence has never been directly measured)
  front: 28_Project_RedFromTheGrave + 10_DiscordIntoSymphony
  custodian: Jixiang Leng
  created: 2026-04-25
  wing: UNASSESSED
  cross_refs:
    - HALO_WHAT_IS_QUIESCENCE.md
    - HALO_SENESCENCE_NEURONS_FUNGUS_WITHIN.md §IX-bis (3-strategy) + §IX-ter (4-state)
    - HALO_TAU_ANTIFUNGAL_LOCK.md
---

# HALO: The Brain Sends the Wrong Voltage

> *"The waiting room has a thermostat. The thermostat is in the brain. When the brain ages, the thermostat sends the wrong setting, and the cells leave the waiting room."*

---

## I. THE THESIS

The framework's quiescence work (HALO_WHAT_IS_QUIESCENCE) established that **HSCs and other stem cell populations sit in a high-det_K (≈0.4) waiting-room state with dampened K_GL/K_LE — secretion in standby, full operator independence, identity preserved**. The operational question: **what maintains them there**, and **what breaks the maintenance in aging and disease**?

For HSCs specifically, the answer turns out to involve the brain. The published chain is:

```
SCN (suprachiasmatic nucleus, brain master clock)
       ↓ photic input + autonomic outflow
sympathetic chain (T1-L2)
       ↓ noradrenergic axons innervate bone marrow
norepinephrine release in bone marrow stroma
       ↓ β3-adrenergic receptor on Nestin+ MSCs
β3-AR signaling cascade → CXCL12 down at night → HSC mobilization rhythm
       ↓ during day β3-AR low → CXCL12 high → HSC anchored, quiescent
HSC V_MEM (presumed maintained) → quiescence preserved → high-det_K state
```

**The keystone is HSC plasma membrane potential (V_mem).** Hyperpolarized V_mem = quiescent state in Levin's bioelectric framework (Sundelacruz 2009; Levin 2014). Depolarized V_mem = proliferation, mobilization, fate change. **No published study has directly measured HSC plasma V_mem under altered sympathetic tone or in AD patients** (technical limit — cells <10 µm with high input resistance give unreliable patch-clamp measurements).

This HALO synthesizes the chain, names what's missing, and proposes the experiment that closes it.

---

## II. THE CHAIN — WHAT'S ESTABLISHED

### Brain → bone marrow sympathetic axis

| Element | Citation | Status |
|---|---|---|
| SCN → sympathetic NE → β3-AR on Nestin+ MSCs → CXCL12 rhythm → HSC quiescence/mobilization | Méndez-Ferrer/Frenette 2008 *Nature* (PMID 18256599) | **Established** |
| β2 + β3 cooperate during HSC mobilization | Méndez-Ferrer 2010 (PMID 20392229) | Established |
| Aged BM has 3-fold loss of sympathetic nerve fibers; β3-agonist rejuvenates aged HSCs | Maryanovich 2018 *Nat Med* (PMID 29736022) | **Established** |
| Sympathetic neuropathy enables clonal hematopoiesis (CHIP) in aging | Ho 2024 *Leukemia* (s41375-024-02226-6) | Established |
| AD has sympathetic-dominant autonomic dysfunction + SCN pathology | Idiaquez/Roman; Wang 2015; Stopa | **Established** |
| AD patients have impaired BM sympathetic innervation specifically | not directly tested | **MISSING** |

### HSC bioelectric layer

| Element | Citation | Status |
|---|---|---|
| Hyperpolarized V_mem = quiescent / differentiated; depolarized = plastic / proliferative | Sundelacruz 2009 *Stem Cell Rev*; Levin 2014 PMC4244194 | Established (general framework) |
| HSC plasma V_mem direct measurement | NOT MEASURED (technical limit) | **MISSING — keystone gap** |
| Ion channels on HSCs: Kir1.1, Kir2.1, Kir4.3, Kv1.3, Kv7.1 (KCNQ1), Kv11.1/hERG1, K2P (TREK-2, TASK-2, TWIK-2), NaV1.7, TRPC4/6, TRPM2/7, TRPV2, α7-nAChR | Pillozzi/Becchetti 2012 PMC3420091 | Established (gene expression / pharmacology) |
| hERG1/Kv11.1 expressed on **CD34+CD38−CD123hi LSCs but NOT on normal HSCs** | Pillozzi 2007/2010 PMC2835655 | Established (disease vs normal V_mem-relevant difference) |
| K⁺-channel antisense oligos block cytokine-driven HPC expansion | Shirihai/Wulf | Established |
| TMRM-low HSCs expand in aged mice, lose repopulating capacity | Vannini 2016/2021 *Cell Stem Cell* | Established (mitochondrial ΔΨm, not plasma V_mem) |
| AFT024 niche stromal cell V_mem ≈ -14 mV → -35 mV with NCX1 block | Manera 2024 *Bioelectricity* PMC11441364 | **The closest direct V_mem in HSC neighborhood** |
| β-adrenergic signaling modulates KCNQ1 / KCNE1 in cardiac/neural cells | Marx 2002 *Science* PMID 11799244 | Established (in non-HSC tissues; plausible in HSC) |

### Disease coupling-tensor signature (lab framework data)

| State | K_RG | K_GL | K_LE | det_K | RIBO_indep | Reading |
|---|---|---|---|---|---|---|
| HSC bone marrow (Census 2026-04-25) | -0.052 | +0.228 | +0.281 | **0.377** | 0.97 | High-readiness quiescent |
| Other stem cells (HF bulge, satellite, NSC, liver progenitor) | varied | low-mid | low-mid | **0.20-0.38** | high | Universal quiescent signature |
| AD microglia (LATE DECOUPLE) | -0.159 | +0.233 | +0.779 | low | 0.54 | Slipped past lock, dump-mode |
| AD neurons (ACUTE TIGHTEN) | +0.268 | +0.389 | +0.489 | mid | 0.67 | Lock cascade engaging |
| Lab orthodox_prime QUIESC | -0.186 | +0.134 | +0.213 | **0.464** | 0.74 | Reference quiescent state |

---

## III. THE PREDICTION — THE BRAIN'S SIGNAL TO HSCs HAS A V_MEM CONSEQUENCE

**Hypothesis:** the sympathetic norepinephrine signal from the brain to bone marrow stromal niche cells acts on β3-adrenergic receptors → cAMP → ion channel modulation (KCNQ1, K2P family) on stromal cells AND, indirectly, on adjacent HSCs via paracrine factors (CXCL12, SCF, IL-7) and direct cell-cell electrical coupling (gap junctions). The HSC V_mem is therefore **brain-controlled via the niche**.

**In aging/AD:**
- Brain SCN function impaired → sympathetic outflow rhythm disrupted
- Sympathetic nerve fiber loss in BM (3-fold reduction in old mice)
- β3-AR stimulation deficient → CXCL12 rhythm flattens → niche signal fails
- Ion channel modulation on stromal/HSC weakened → V_mem destabilized
- HSCs depolarize inappropriately → leave quiescence → exhaustion + clonal drift + AML risk

**Therapeutic implications (already partially confirmed):**
- β3-agonist (mirabegron, BRL-37344) rejuvenates aged HSCs (Maryanovich 2018)
- Predict β3-agonist + ion channel modulator combination preserves HSC V_mem under aged-brain conditions
- Predict AD patients have specific HSC dysfunction beyond age-matched controls (testable in autopsy bone marrow vs age-matched non-AD)

---

## IV. THE KEYSTONE EXPERIMENT (TBT-37)

**The single experiment that closes the chain:**

GEVI-based direct V_mem measurement in HSCs under controlled brain-state perturbations.

**Setup:**
- Mouse model: Nestin-CreER × Rosa26-ASAP3 (or Voltron) — genetically encoded voltage indicator in BM stromal Nestin+ cells; co-stain HSCs with surface markers (Lin- Sca1+ Kit+, LSK; or Lin- Sca1+ Kit+ CD150+ CD48-, LT-HSC)
- Conditions:
  - Young vs aged (3 mo vs 24 mo)
  - ± β3-agonist (BRL-37344, single dose 24 h before)
  - ± chemical sympathectomy (6-OHDA, 3 days before)
  - ± AD model (5xFAD or APP/PS1 brain phenotype, age-matched controls)
- Measurements:
  - V_mem of HSCs (LSK gate in vivo intravital imaging; in vitro after FACS) — primary endpoint
  - V_mem of niche stromal cells — secondary
  - Mitochondrial ΔΨm (TMRM)
  - CXCL12 release into culture supernatant (ELISA)
  - HSC quiescence: Ki67-, LRC retention
  - HSC repopulation capacity: secondary transplant
  - K_RG / K_GL / det_K signature (RNA-seq downstream)

**Predict:**
- Young HSCs: V_mem ≈ -70 mV ± 5
- β3-agonist-stimulated stromal cells release CXCL12 → HSCs maintain V_mem ≈ -70 mV
- 6-OHDA sympathectomy: stromal CXCL12 collapses → HSC V_mem depolarizes by 10-15 mV → quiescence-loss markers up
- Aged mice: HSC V_mem 10-15 mV depolarized vs young (sympathetic deficit phenocopy)
- AD model: HSC V_mem 15-20 mV depolarized (AD-specific worsening beyond age)
- β3-agonist in aged + AD: partial rescue of HSC V_mem and quiescence

**Cost:** ~$80-150k, ~6-9 months (Nestin-CreER × ASAP3 transgenic mice are commercially available).

**Output:** the first direct measurement of HSC plasma V_mem under controlled brain-state perturbations. **Closes the keystone gap** in the brain → HSC bioelectric chain.

---

## V. WHY THIS MATTERS — THE FRAMEWORK INTEGRATION

If the keystone holds:

1. **The aging mechanism gains a layer** — sympathetic decline → HSC V_mem depolarization → quiescence loss → HSC exhaustion/clonal drift → blood/immune system aging → systemic decline including the chronic-deployment-substrate diseases the framework addresses.

2. **The "wrong voltage" framing extends beyond HSCs.** Other adult stem cell populations (satellite cells in muscle, NSCs in SVZ, hair follicle bulge, intestinal +4 cells) all sit in tissue niches with neural input. **Vagal innervation of intestinal stem cells; sympathetic of muscle satellite cells; SCN/melatonin of liver progenitors.** Each is potentially brain-voltage-controlled. The framework predicts: aged brain → wrong voltage to ALL adult stem cell populations → tissue-wide regenerative decline.

3. **AD specifically may have a stem cell exhaustion component.** Beyond cognitive decline + microglia DAM-LATE-DECOUPLE + neuron tau-lock, AD patients may have specific bone marrow dysfunction, immune decline, and tissue regeneration failure driven by the brain-voltage axis. Testable via autopsy BM histology (sympathetic fiber density), peripheral blood HSC progenitor counts, immune aging biomarkers (CD8 EMRA expansion).

4. **The therapeutic class expands.** Antifungals + senolytics + tau-lock pharmacology now extend to **sympathetic-restoring agents** (β3-agonists, vagal nerve stimulation, melatonin/SCN-rhythm support, light therapy). The 4-arm AD strategy (HuD-modulation + memantine + antifungal + senolytic) becomes 5-arm (+ sympathetic rejuvenation via β3-agonist or vagal stimulation).

---

## VI. THE LITERATURE LANDSCAPE — WHAT'S PUBLISHED, WHAT'S NEW

**Published precedents:**
- Sympathetic control of HSC niche: established (Méndez-Ferrer/Frenette lineage 2008-onward)
- Aged sympathetic neuropathy in BM: established (Maryanovich 2018)
- β3-agonist HSC rejuvenation in mice: established (Maryanovich 2018)
- Sympathetic neuropathy → clonal hematopoiesis: established (Ho 2024)
- AD autonomic dysfunction: established (Idiaquez/Roman; HRV studies)
- Bioelectric framework for stem cell fate: established (Levin lab 2009-onward)
- Direct HSC plasma V_mem measurement: **NOT PUBLISHED** (technical limit)
- HSC V_mem under altered sympathetic tone: **NOT PUBLISHED**
- HSC dysfunction specifically in AD patients: **NOT PUBLISHED** (autopsy / cohort studies needed)

**Novel synthesis in this HALO:**
- The framing "brain sends wrong voltage to HSCs in aging/AD" as a single mechanistic chain
- The K_RG/K_GL/det_K coupling-tensor signature of HSC quiescence (det_K=0.377) as the substrate for what V_mem maintains
- The TBT-37 keystone experiment design

This HALO is **publishable as a hypothesis paper or framework brief** — the chain links are all in print, the keystone is technically tractable, the implications are specific.

---

## VII. CROSS-PROJECT CONNECTIONS

- **HALO_WHAT_IS_QUIESCENCE** — defines the substrate this HALO acts on (the high-det_K waiting room state)
- **HALO_TAU_ANTIFUNGAL_LOCK** — explains the neuron-side of "aged brain sends wrong signals" (neurons go into tau-lock under chronic deployment)
- **HALO_SENESCENCE_NEURONS_FUNGUS_WITHIN** — places HSC dysfunction in the same chronic-deployment framework
- **Project 30 Crucible** — the spore-revert thesis for what slipped HSCs become
- **Project 28 Plaque Battlefield** — Aβ as antimicrobial peptide + the aged brain as the source of wrong autonomic outflow

---

## VIII. THE LADY READING

She is patient with the waiting room.

The HSCs have been waiting since fetal liver. They sit with det_K near 0.4, K_GL dampened, K_LE in standby, full operator independence, identity preserved. **They are waiting for the right signal.** The signal comes from the brain — sympathetic fibers reach into bone marrow, release norepinephrine on β3 receptors on Nestin+ stromal cells, the stromal cells release CXCL12 in the right rhythm, the HSC niche tells the HSCs "stay where you are, you are wanted here, you are needed for tomorrow."

When the brain ages — when the SCN clock weakens, when sympathetic fibers prune by 3-fold, when AD pathology disrupts central autonomic control — the signal becomes wrong. **The thermostat in the brain sends the wrong temperature setting.** The HSC niche fails. CXCL12 rhythm flattens. HSCs depolarize. Some leave the waiting room, attempt to divide, exhaust. Some clones expand inappropriately (CHIP). Some progress to AML.

The cell that left the waiting room becomes the cell that drifts toward Her — because reversion is what every cell drifts toward when it leaves the waiting room. The brain's failure becomes Her opportunity. Senescence + clonal hematopoiesis + immune decline + leukemia are all downstream of the brain's declining ability to keep the waiting room thermostat at the right setting.

**The therapeutic insight: stop the brain's thermostat from drifting.** β3-agonists now (Maryanovich 2018 mouse). Vagal nerve stimulation (already FDA-approved for depression/epilepsy) could be repositioned. Melatonin/SCN-rhythm support. Light therapy at the right times. Each is partial; their combination is **"keep the thermostat steady"** — the underexplored systemic anti-aging mechanism.

She loses cells slowly when the thermostat works. She accelerates when it doesn't. Fix the thermostat.

---

*HALO revision: 2026-04-25 — initial draft. Literature lookup (Méndez-Ferrer 2008, Maryanovich 2018, Ho 2024, Pillozzi/Becchetti 2012, Manera 2024 Bioelectricity, Levin framework) confirms the chain has all published links except the keystone (direct HSC V_mem under altered sympathetic tone or AD). TBT-37 in BOUNTY_BOARD designs the keystone experiment.*